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Staphylococcus aureus is an important human pathogen commonly infecting nearly every
host tissue. The ability of S. aureus to resist innate immunity is critical to its success as a
pathogen, including its propensity to grow in the presence of host nitric oxide (NO·). Upon
exogenous NO· exposure, S. aureus immediately excretes copious amounts of L-lactate
to maintain redox balance. However, after prolonged NO·-exposure, S. aureus reassim-
ilates L-lactate speciﬁcally and in this work, we identify the enzyme responsible for this
L-lactate-consumption as a L-lactate-quinone oxidoreductase (Lqo, SACOL2623). Originally
annotated as Mqo2 and thought to oxidize malate, we show that this enzyme exhibits no
afﬁnity for malate but reacts speciﬁcally with L-lactate (KM =∼330μM). In addition to its
requirement for reassimilation of L-lactate during NO·-stress, Lqo is also critical to res-
piratory growth on L-lactate as a sole carbon source. Moreover, Δlqo mutants exhibit
attenuation in a murine model of sepsis, particularly in their ability to cause myocarditis.
Interestingly, this cardiac-speciﬁc attenuation is completely abrogated in mice unable to
synthesize inﬂammatory NO· (iNOS−/−). We demonstrate that S. aureus NO·-resistance
is highly dependent on the availability of a glycolytic carbon sources. However, S. aureus
can utilize the combination of peptides and L-lactate as carbon sources during NO·-stress
in an Lqo-dependent fashion. Murine cardiac tissue has markedly high levels of L-lactate
in comparison to renal or hepatic tissue consistent with the NO·-dependent requirement
for Lqo in S. aureus myocarditis. Thus, Lqo provides S. aureus with yet another means of
replicating in the presence of host NO .·
Keywords: Staphylococcus aureus, lactate-quinone oxidoreductase, virulence, myocarditis, pericarditis,
metabolism
INTRODUCTION
Staphylococcus aureus is a pathogen of tremendous importance to
human health (Diekema et al., 2001). The Gram-positive bac-
terium can be commonly isolated from nasal passages, axillae,
and perinea of healthy carriers (Mermel et al., 2011). While the
most common disease presentations of S. aureus are skin/soft tis-
sue infections, it is also a frequent cause of sepsis, endocarditis,
and osteomyelitis (Klevens et al., 2007). The latter conditions can
be complicated by bacterial spread to cardiac muscle resulting
in purulent abscesses or myocarditis (Wasi and Shuter, 2003). S.
aureus can also seed the pericardial space resulting in pericarditis
necessitating surgical drainage followed by extensive intravenous
antibiotic administration (Klacsmann et al., 1977; Mookadam
et al., 2009). While pericarditis and myocarditis are not the most
frequent disease presentations associatedwith S. aureus infections,
this organism is the one of the most common causes of both
life-threatening conditions (Wasi and Shuter, 2003; Mookadam
et al., 2009). It is thought that myocarditis and pericarditis are
rare complications of sepsis because bacteria in general do not
efﬁciently colonize muscle tissue. Indeed, bacterial infections in
skeletal muscles (pyomyositis/myositis) are even more rare than
infections of cardiac muscle tissue. However, as with pericarditis
andmyocarditis, themost common cause of bacterialmyositis and
pyomyositis is S. aureus (Pannaraj et al., 2006). Thus, this pathogen
has a propensity to colonize and thrive in nearly every sterile site
in the body, even environments not conducive to supporting most
other bacterial pathogens.
In order for S. aureus to inhabit sterile sites within the human
body, it must be able to resist numerous host innate immune effec-
tors (Foster, 2005). Nitric oxide (NO·) is a key broad-spectrum
antimicrobial host effector that is essential for the efﬁcient clear-
ance of a variety of microbial pathogens (DeGroote and Fang,
1999). As with most other immune effectors, S. aureus is uncom-
monly resistant to the effects of exogenous NO· (Richardson et al.,
2006, 2008; Hochgrafe et al., 2008). This NO·-resistance results
from the induction of ametabolic state that circumvents the effects
of this cytotoxic radical (Richardson et al., 2008). NO· is known to
interfere with various bacterial metabolic pathways including the
tricarboxylic acid cycle, aerobic respiration, fatty acidmetabolism,
pyruvatemetabolism,andnucleic acid synthesis (Richardson et al.,
2008, 2009, 2011).While we do not fully understand how S. aureus
accommodates the loss of multiple NO·-sensitive targets, progress
has been made with regard to S. aureus adaptation to the redox
imbalance associated with NO·-stress. Upon exposure to exoge-
nous NO·, S. aureus ceases to respire and shifts into a fermentative
metabolic state concomitant with increased excretion of l-lactate
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(Richardson et al., 2008). The reduction of pyruvate to l-lactate
provides redox balance by regenerating NAD+ in a cell unable to
utilize the respiration-dependent NADH-dehydrogenase (Com-
plex I of the electron transport chain). In S. aureus most of
the l-lactate production is catalyzed by lactate dehydrogenase 1
(Ldh1), an allele that is unique to S. aureus and not found in
other staphylococci (Richardson et al., 2008). Coincidentally,other
staphylococcal species are incapable of robust growth duringNO·-
stress (Richardson et al., 2008). S. aureus additionally possesses
another l-lactate dehydrogenase (Ldh2) that is shared amongmost
other staphylococcal species. However, Ldh2 is expressed even in
the absence of NO· and, given the strong induction of ldh1 fol-
lowing NO·-exposure, Ldh2 offers only a minor contribution to
redox balance during NO·-stress (Richardson et al., 2008). Finally,
S. aureus encodes a d-lactate dehydrogenase (Ddh) that also pro-
duces d-lactate during NO·-exposure, albeit to a much lower level
than the l-enantiomer. Thus, S. aureus possesses three lactate-
dehydrogenases all of which regenerate NAD+ with Ldh1 playing
the major redox-balancing role during growth in the presence of
exogenous NO·.
However, a series of elegant studies conducted nearly a half-
century ago characterized NAD-independent l-lactate dehydro-
genase (iLDH) activity in S. aureus (Stockland and San Clemente,
1969). iLDHs oxidize l-lactate to pyruvate with a concomi-
tant reduction of the respiratory quinone pool (Stevenson and
Holdsworth, 1973). Electrons are eventually donated to termi-
nal acceptors, and in S. aureus l-lactate oxidation was shown
to be coupled to the reduction of ferric iron, oxygen, or nitrate
(Theodore and Weinbach, 1974; Lascelles and Burke, 1978;
Tynecka andMalm, 1995).While many iLDH enzymes exist in the
microbial world, no such gene is annotated in any of the current
S. aureus genome sequences (more than 14 to date; Stevenson and
Holdsworth, 1973). Moreover, homology searches using known
iLDH sequences were unsuccessful at identifying a gene encoding
such an enzyme in S. aureus. Thus, the identiﬁcation of a putative
fourth lactate utilization gene responsible for observed enzymatic
activity has proved elusive.
Here we identify the gene encoding the S. aureus iLDH as
SACOL2623 originally annotated as Mqo2, a malate-quinone oxi-
doreductase. Given that malate is chemically similar to l-lactate
and that malate- and l-lactate-dependent enzymes are phyloge-
netically related, the coding genes are occasionally misannotated
(Madern, 2002). We show that puriﬁed Mqo2 has no afﬁnity for
malate and thus we suggest the protein be renamed Lqo. We
characterize the contribution of Lqo to S. aureus catabolism of
l-lactate both in the presence and absence of exogenous NO·.
Lqo orthologs are present, within similar genetic environments,
in the sequenced genomes of all Staphylococcus species. We also
deﬁne a role for Lqo in S. aureus virulence in a murine model of
sepsis. Speciﬁcally Δlqo mutants are defective for growth within
murine cardiac tissue in the presence of host NO·. We show that
while S. aureus NO·-resistance is predicated on the presence of
a glycolytic carbon source, speciﬁcally combining l-lactate with
peptides also provides S. aureus with the means to replicate in the
presence of NO· in an Lqo-dependent manner. The high levels of
both l-lactate and protein in murine cardiac tissue are consistent
with the speciﬁc NO·-dependent requirement for Lqo in murine
septic myocarditis/pericarditis. Thus, Lqo represents a key meta-
bolic enzyme allowing S. aureus to utilize elevated host l-lactate
associated with active muscle tissue and, at the same time, resist
the cytostatic effects of host NO·.
RESULTS
STAPHYLOCOCCUS AUREUS HARBORS AN UNIDENTIFIED L-LACTATE
CATABOLIC ENZYME
Upon exposure to exogenous NO·, S. aureus evokes fermentative
metabolism to contend with the propensity of NO· to block res-
piration. Accordingly, l-lactate, and to a lesser extent, d-lactate
are both produced from pyruvate providing the cell with redox
balance (Figures 1A,B). However, after prolonged exposure to
NO·, l-lactate is speciﬁcally reassimilated but d-lactate is not
(Figure 1B). It should be noted that this l-lactate-consumption
occurs despite the presence of excess glucose (data not shown).
We reasoned that reversal of the NAD-dependent Ldh1, Ldh2,
or Ddh reactions was not responsible for the observed l-lactate-
consumption, because: 1. the reverse reaction would be detrimen-
tal to the redox state of the cell and 2. both l-lactate and d-lactate
would have been consumed since both reactions are reversible,
enzymes for both l-lactate and d-lactate are highly expressed dur-
ing NO·-stress (Richardson et al., 2006) and both enantiomers
can support growth of WT S. aureus. Indeed, Ddh allows for d-
lactate production anaerobically as well as its aerobic utilization
(Figure 1C). Moreover, the Δddh mutant can neither produce
nor consume d-lactate (Figure 1C). In contrast, while mutants
lacking Ldh1 and Ldh2 do not produce l-lactate anaerobically,
the Δldh1Δldh2 mutant still grows aerobically on l-lactate as a
sole carbon source (Figure 1C). This is not due to racemase activ-
ity converting l-lactate tod-lactate as the tripleΔldh1Δldh2Δddh
mutant still grows on l-lactate aerobically (data not shown). Thus,
S. aureus must encode another l-lactate catabolic enzyme that is
irreversible (no l-lactate production in the Δldh1Δldh2 mutant)
and likely does not use NAD+ as a cofactor as this would represent
a futile cycle with the high Ldh1 levels in NO·-exposed cells. The
enzyme responsible for the previously described iLDH activity
could explain these observations.
SACOL2623 (mqo2) ENCODES THE S. AUREUS iLDH ACTIVITY
No gene in any sequenced S. aureus genome is predicted to encode
a putative iLDH, nor are there any identiﬁable homologs of well-
characterized iLDH genes in S. aureus. However, S. aureus does
encode two malate-quinone oxidoreductases (Mqo1 and Mqo2)
that are thought to participate in the TCA cycle since this organ-
ism lacks an NAD-dependent malate dehydrogenase (Figure 2A).
These enzymes are predicted to use an FAD-cofactor to assist in
transferring electrons directly to the respiratory quinone pool, and
therefore would oxidize their substrates independently of NAD+.
Since malate and lactate are structurally similar in that malate is
essentially a carboxylated lactate (Figure 2A),we reasoned that one
or both of the annotated Mqo enzymes may react with l-lactate
and encode the S. aureus iLDH. Indeed, combining a deletion
of mqo2, but not mqo1, with the Δldh1Δldh2 mutation abol-
ished the ability to grow aerobically on l-lactate as a sole carbon
source (Figure 2B). Thus, despite the juxtaposition of mqo1 to
a gene encoding a predicted l-lactate permease (Figure 2A), it
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FIGURE 1 | Staphylococcus aureus encodes a fourth biologically relevant
L-lactate utilization enzyme. (A) Known metabolic end products of S.
aureus glucose catabolism. (B) Levels of extracellular D-lactate (light blue
squares) and L-lactate (dark blue squares) following exposure to exogenous
NO· (red circles). Cells were grown in chemically deﬁned medium to an
OD660 =0.15 (black circles) at such time a combination of NO·-donors (10mM
NOC-12 and 1mM DEA/NO) was added. The resulting NO· burst peaked at
1.5 h at ∼1mM. (C) Δddh mutants (LEFT) no longer excrete D-lactate
anaerobically (inset) and speciﬁcally lack the ability to grow on D-lactate as a
primary carbon source. In contrast, while Δldh1Δldh2 mutants (RIGHT) do
not produce measurable L-lactate anaerobically (inset), the double mutant is
still able to utilize L-lactate as a primary carbon source. Residual growth on
medium components was subtracted from depicted growth curves (see
Materials and Methods).
appears that Mqo2 reacts with l-lactate (Figure 2B). Addition-
ally, a Δmqo2 mutant, but not Δmqo1, was unable to reassimilate
l-lactate during prolonged NO·-exposure (Figure 2C). However,
the lack of l-lactate-reassimilation in the Δmqo2 mutant had lit-
tle reproducible effect on growth in the presence of NO· when
glucose was used as the primary carbon source, and there were
no effects on the rate of glucose consumption nor glucose yield
(mg biomass/mg glucose consumed, data not shown). These data
suggest that Mqo2 can oxidize l-lactate to pyruvate and therefore
comprises the S. aureus iLDH activity. However, while S. aureus
iLDH is active in the presence of NO· (Figure 1B), its role during
growth on glucose under NO·-stress is still unclear.
In order to distinguish between Mqo2 having dual speciﬁci-
ties and the possibility that it only has afﬁnity for l-lactate, we
performed enzymatic assays on membrane fractions from single
mutant strains to determine substrate speciﬁcity. The Δmqo1
mutant (only expressing Mqo2) exhibited l-lactate-speciﬁc activ-
ity but no real activity with malate (Figure 3). Conversely,
a Δmqo2 mutant membrane preparation reacted readily with
malate, but not l-lactate (Figure 3). Membrane preparations
from neither the Δmqo1 nor the Δmqo2 mutant reacted with
d-lactate or pyruvate suggesting that Mqo2 was speciﬁc for l-
lactate and the enzyme was non-reversible (data not shown).
Finally, His6-tagged versions of both enzymes were puriﬁed
and afﬁnities for malate and l-lactate were determined in an
in vitro enzyme assay. While Mqo2 had signiﬁcant afﬁnity for
l-lactate (KM =∼300μM, Figure 3), it did not react readily
with malate. Again, Mqo1 had high afﬁnity for malate but no
detectible reaction with l-lactate (Figure 3). Since Mqo2 does not
exhibit any substrate speciﬁcity for malate and efﬁciently oxidizes
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FIGURE 2 | Mqo2 is responsible for the elusive S. aureus iLDH activity.
(A) Genetic organization of the two annotated malate-quinone oxidoreductase
genes. mqo1 is between an L-lactate permease and a hypothetical gene,
while mqo2 is found between a putative acetyl-CoA synthase (acs,
SACOL2624) and a class I fructose 1,6-bisphosphate aldolase, fdaB. (B)
Speciﬁcally combining a Δmqo2 mutation to the Δldh1Δldh2 background
abolishes the ability to utilize L-lactate. Cells were grown aerobically in
chemically deﬁned medium with 0.2% L-lactate as the primary carbon
source. Residual growth on medium components was subtracted out of
depicted curves (see Materials and Methods). (C)The L-lactate excreted
following NO·-exposure cannot be reassimilated in a Δmqo2 mutant. Cells
were grown in chemically deﬁned medium as described in Figure 1B.
FIGURE 3 |The S. aureus Lqo enzyme oxidizes L-lactate and has no
affinity for malate. Left: Membrane preparations from single mutant
S. aureus were assayed for Lqo and Mqo activity. Δmqo1
(Lqo-containing) membranes react readily with L-lactate but not malate.
In contrast, Δmqo2 mutants (Mqo-containing) have activity against
malate but not L-lactate. Right: Puriﬁed His6-tagged versions of Lqo
and Mqo were used to determine afﬁnities of each enzyme to its
cognate substrate.
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l-lactate, we suggest that it be renamed Lqo (l-lactate-quinone
oxidoreductase).
We assessed the physiological roles for Lqo in growth on var-
ious carbon sources in the presence/absence of different electron
acceptors. As expected, mutants lacking Lqo showed measurable
defects when grown on l-lactate and these defects were additive
when Δlqo was combined with Δldh2 (Figure A1 in Appendix).
The loss of Ldh1 had little effect on l-lactate utilization consistent
with its role in producing l-lactate for redox balance (Figure A1 in
Appendix). When S. aureus was grown aerobically in media with
amino acid carbon sources, Lqo was dispensable (Figure A2 in
Appendix). In contrast a Δmqo mutant was measurably impaired
in this medium underscoring its role in the TCA cycle, a pathway
essential to the utilization of amino acids (Figure A2 in Appen-
dix). Regardless of the medium used to cultivate S. aureus, lqo
transcript was highly abundant, though expression was signiﬁ-
cantly lower in the presence of glucose (Figure A3 in Appendix).
Interestingly, lqo was still highly expressed in the Δldh1Δldh2
mutant grown on glucose, an environment completely devoid of
l-lactate (data not shown). Anaerobically, S. aureus was unable to
grow on l-lactate as a carbon source unless an electron accep-
tor (e.g., nitrate) was also present (Figure A4A in Appendix).
This result highlights the respiratory nature of Lqo in that it
reduces the quinone pool therefore necessitating the presence of
a terminal electron acceptor such as oxygen or nitrate. Interest-
ingly, Δlqo S. aureus could still grow anaerobically on l-lactate
in the presence of nitrate implying that Ldh1 and/or Ldh2 can
also serve as catabolic enzymes provided the resulting NADH
is recycled through a respiratory mechanism (Figure A4A in
Appendix). Moreover, combining peptides (1% Tryptone) with
l-lactate greatly improved anaerobic growth both in the pres-
ence and absence of nitrate (Figure A4B in Appendix). How-
ever, in the absence of nitrate, the added beneﬁt of peptides
combined with l-lactate was independent of Lqo and required
Ldh1/2 in line with the absence of a deﬁned electron acceptor
(Figure A4B in Appendix). In contrast, as with l-lactate alone
(Figure A4A in Appendix), addition of nitrate facilitated Lqo-
dependent growth on peptide/l-lactate in that the Δldh1Δldh2
mutant grew nearly as well asWT (Figure A4B in Appendix). Col-
lectively, these data show that Lqo plays a pivotal role in S. aureus
metabolism when utilizing l-lactate speciﬁcally under respiratory
conditions.
STAPHYLOCOCCUS AUREUS Lqo IS REQUIRED FOR FULL VIRULENCE IN
A MURINE SEPSIS MODEL
Infecting mice i.v. with 5× 106 cfu of S. aureus strain Newman
results in reproducible weight loss over the ﬁrst week of infection
(Figure 4). Roughly half of the mice lost ≥30% original body
weight within the ﬁrst week post-inoculation and were sacriﬁced
as per approved IACUC protocols. In contrast, mice infected with
an isogenic Δlqo mutant exhibited signiﬁcantly (p < 0.01) slower
weight loss kinetics with all of the mice maintaining ≥70% of
their original body weight (Figure 4). In competitive i.v. infec-
tions withWT strain Newman, the Δlqo mutant showed amarked
defect in the heart, but only a modest ∼3-fold attenuation in
the kidney (Figure 4). In mice unable to produce inﬂamma-
tory NO· (iNOS−/−), the heart-speciﬁc competitive defect was
FIGURE 4 | Lqo is required for full S. aureus virulence in a murine
sepsis model, particularly in establishing myocarditis. Left: Eight 4-to
6-week female C57BL/6 mice (two independent experiments each with
four mice per group) were inoculated i.v. with 5×106 cfu of S. aureus strain
Newman (blue circles) or isogenic Δlqo (red diamonds). Weight loss was
monitored following inoculation and presented as percent initial body
weight. Once mice lose ≥30% of their original body weight, they are
sacriﬁced as per IACUC protocol. WT infected mice exhibited signiﬁcantly
greater weight loss (p <0.01, using longitudinal linear regression to model
weight loss over time, SAS®, Cary, NC, USA) and four (50%) were
sacriﬁced (indicated with X). Right: Competitive indices (C.I.) were
established by infecting mice i.v. with 1×107 cfu of a 1:1 mixture ofWT:
Δlqo S. aureus strain Newman. Organs were harvested 5 days
post-inoculation and mutant:WT C.I. ratios were calculated as outlined in
experimental procedures. In parallel, isogenic iNOS−/− mice unable to
produce inﬂammatory NO· were also infected in a similar manner.
fully reversed while the modest defect in the kidneys was still
observable (Figure 4). Thus, S. aureus Lqo contributes to viru-
lence in both an iNOS-dependent and -independent fashion and
mutants exhibit tissue-speciﬁc defects in competition with WT
S. aureus.
The fact that the Δlqo virulence defect was partially reversed
in iNOS−/− mice was surprising given the lack of an in vitro
NO·-phenotype when the mutant was grown on glucose (data not
shown). Glucose is generally used in deﬁned medium for in vitro
experiments because glycolytic carbon sources support S. aureus
NO·-resistance while gluconeogenic sources do not (i.e., pyruvate,
lactate, peptides, Figure 5A). However, combining l-lactate with
peptides will support S. aureus growth under NO·-stress, and this
phenomenon is speciﬁc for l-lactate versus d-lactate and depen-
dent on Lqo (Figure 5A). Furthermore, providing the product of
Lqo (0.1% pyruvate) in combination with peptides also supported
growth during NO·-stress and as expected this was independent
of Lqo (data not shown). We therefore hypothesized that Lqo
was necessary for growth under NO·-stress in the murine heart
because of its requirement for replication using the combination
of peptides and l-lactate during NO·-exposure, and not because
of its role in reassimilation of excreted l-lactate during growth on
glucose.
Bacteria enumerated frommurine heart tissue are foundwithin
abscesses associated with the cardiac muscle (myocarditis) or in
some cases with the pericardial space (pericarditis; Figure 5B).
Hematogenous myocarditis/pericarditis occurs regularly in the
murine sepsis model in that bacteria are consistently isolated from
cardiac tissue, though visible abscesses are not always present.
Histological examination of infected tissue revealed inﬁltration
of many granulocytic cells as well as other distinct cell types
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FIGURE 5 | Staphylococcus aureus growth in L-lactate-rich cardiac
tissue in the presence of host NO· requires Lqo. (A) Individual
gluconeogenic carbon sources (e.g., 1.0% L-lactate or 1.0% tryptone)
do not support NO· resistance in chemically deﬁned medium as does
0.5% glucose. However, combining 0.1% L-lactate with 1.0% tryptone
allows S. aureus to grow in the presence of NO·. NO· in the form of
10mM DETA/NO was added once cells reach an OD660 =0.15 depicted
here as t 0. (B) Myocardial abscesses in mice infected withWT S.
aureus Newman 5days post-inoculation. Left, hematoxylin and eosin
staining of abscess reveal a central bacterial microcolony (black arrow)
surrounded by inﬁltrating granulocytic cells. Center,
immuno-histoﬂuorescent staining of the same abscess with anti-iNOS
monoclonal Ab reveals robust iNOS expression throughout the abscess.
Tissue was counter-stained with DAPI to reveal host cell nuclei.
Non-staining S. aureus microcolony is visible (white arrow). Right,
identical immuno-histoﬂuorescent staining of a similar abscess in an
iNOS−/− mouse as a negative control for anti-iNOS Ab. Tissue was also
counter-stained with DAPI. (C) Metabolite data from murine tissues
were determined using enzymatic methods previously described and
normalized to total organ weight.
surrounding micro-colonies of bacteria (Figure 5B). Immuno-
histological examination using anti-iNOS antibodies conﬁrmed
high-level iNOS expression in myocardial abscesses around S.
aureus micro-colonies (Figure 5B). In comparison to other tis-
sue commonly colonized hematogenously during S. aureus sepsis
(e.g., hepatic and renal), cardiac tissue had by far the highest lev-
els of l-lactate in addition to protein (Figure 5C). This is likely
true for all active muscle tissue in mammals and is consistent
with the speciﬁc requirement of Lqo for myocarditis/pericarditis
in NO·-proﬁcient hosts.
DISCUSSION
The existence of NAD-independent lactate dehydrogenase (iLDH)
activity in S. aureus was ﬁrst described over 50 years ago, but
received little attention over the NAD-dependent enzymes (Stock-
land and San Clemente, 1969). The S. aureus iLDH activity was
again reported 4 years later and shown to be speciﬁc for l-lactate
(Stevenson andHoldsworth,1973). Subsequently, this iLDHactiv-
ity was shown to be membrane associated and was linked to the
reduction of ferric iron, nitrate, or oxygen as terminal electron
acceptors (Theodore and Weinbach, 1974; Lascelles and Burke,
1978; Tynecka and Malm, 1995). However, pure fractions con-
taining only the S. aureus iLDH were never used to identify the
protein. Thus,prior to thiswork, the gene(s) encoding the S. aureus
iLDH was never identiﬁed, nor was this activity shown to be bio-
logically relevant. We that the Δldh1Δldh2 mutant, which does
not produce any l-lactate, was still able to grow on l-lactate as a
sole carbon source (Figure 1). Since lactate-racemic activity has
been reported in a singular strain of S. aureus (Stockland and San
Clemente, 1969), the triple Δldh1Δldh2Δddh mutant was tested
and shown to still utilize l-lactate. Thus, the Δldh1Δldh2 mutant
was not racemically converting l-lactate to d-lactate and catabo-
lizing the latter via Ddh. These data are consistent with S. aureus
encoding a true iLDH that will promote growth on l-lactate as a
carbon/energy source.
The ability of the Δldh1Δldh2 mutant to utilize l-lactate was
used to screen two annotated malate-quinone oxidoreductases for
their role in promoting growth on l-lactate given its chemical
similarity with malate. Since malate and lactate utilizing enzymes
are closely related and relatively few amino acid changes can
distinguish the two activities (Yin and Kirsch, 2007), it seemed
reasonable that either mqo1 or mqo2 encoded the S. aureus iLDH.
Mqo2 alone was shown to promote growth of the Δldh1Δldh2
mutant on l-lactate thereby comprising the S. aureus iLDH activ-
ity (Figure 2). The enzyme catalyzes the oxidation of l-lactate
(but notmalate)with the concomitant reduction of menaquinone,
thus we suggest renaming the enzyme Lqo (Figure 3). On the
other hand, Mqo1 was shown to exhibit activity toward malate
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alone and is the only enzyme in S. aureus capable of oxidizing
malate to oxaloacetate, the penultimate reaction of the TCA cycle
(Figure 3). Accordingly, Mqo is essential for maximal growth
on amino acid carbon sources since their assimilation through
the TCA cycle to oxaloacetate is necessary for gluconeogenesis
(Figure A2 in Appendix). Furthermore, Δmqo1 mutants excrete
excess lactate and acetate consistent with the lack of a functional
TCA cycle resulting in “spill-over” metabolism at the pyruvate
node (Figure 2C). In contrast,Δlqo mutants do not excrete excess
acetate since the TCA cycle is fully intact (data not shown). Thus,
Mqo and Lqo are enzymes with distinct, non-overlapping sub-
strates and functions. Notably, both enzymes are essential for full
virulence and Δmqo mutants are severely attenuated underscor-
ing the importance of the TCA cycle for S. aureus pathogenesis
(Somerville et al., 2002; Figure A5 in Appendix).
At ﬁrst glance, it seems illogical to express both Ldh1 and
Lqo under NO·-stress because they would represent futile cycles.
However, given that the electron carriers differ between the Ldh
enzymes and iLDH, their net reaction resembles that of an
alternative (non-proton pumping) NADH-dehydrogenase:
Ldh1/Ldh2 pyruvate +NADH ↔ l-lactate +NAD+ (1)
Lqo l-lactate +MQ=O → pyruvate +MQ-OH (2)
NADH+MQ=O → NAD+ +MQ-OH Net
Perhaps their dual expression provides S. aureus with an
“uncoupled complex I” that can regenerate NAD+ without affect-
ing the proton-motive force. Interestingly, Lqo is still highly
expressed in theΔldh1Δldh2mutant grown on glucose, a scenario
where there is no l-lactate in the environment at all (noneprovided
exogenously and none produced endogenously from glucose). The
constitutive expression of Lqo regardless of the presence/absence
of l-lactate implies that in the host environment, S. aureus always
requires Lqo activity eliminating the need for a complex regulatory
system to control transcription.
When S. aureus is grown on l-lactate as a carbon source, the
role for Lqo is clearly evident. Mutants lacking Lqo exhibit slower
growth and lower overall yields on l-lactate (Figure A1 in Appen-
dix). This phenomenon is exacerbated in the Δldh2 background
and not affected by deletion of ldh1 implying that the major
enzymes for l-lactate catabolism in S. aureus are Lqo and Ldh2
(Figure A1 in Appendix). Anaerobically, S. aureus cannot ferment
l-lactate as a sole carbon source consistentwith the requirement of
a terminal electron acceptor for Lqo function and the fact that the
reversal of Eq. 1 by Ldh1 or Ldh2without a functioning respiratory
chain would lead to redox imbalance (i.e., high NADH, Figures 6
and Figure A4A inAppendix). Simply providing nitrate as an elec-
tron acceptor allows S. aureus to grow anaerobically on l-lactate
using either Lqo or Ldh1/Ldh2 (Figures 6 and Figure A4A in
Appendix). The NAD-dependent LDHs (Ldh1 and Ldh2) catab-
olize l-lactate by the reversal of Eq. 1 presumably coupled to a
respiratory NADH-dehydrogenase. Interestingly, adding peptides
to l-lactate-containing media allowed for growth anaerobically
in the absence of nitrate and this was dependent on Ldh1/Ldh2
(Figure A4B in Appendix). Presumably, excess carbon from pep-
tides frees up l-lactate-derived carbon to establish redox balance.
For instance, some pyruvate generated from l-lactate-oxidation
could be used for energy production while the rest could be
converted to ethanol providing redox balance.Whatever themech-
anism behind peptide stimulated growth under anaerobiosis, Lqo
is not involved because it directly requires active respiration to
generate oxidized quinone for enzymatic activity (i.e., the Δlqo
mutant grows as well as wild type without nitrate, Figure A4B in
Appendix). Thus, S. aureus has evolved multiple means of assimi-
lating l-lactate under various conditions implying its central role
in this pathogen’s metabolic environment. Moreover, Lqo appears
to provide S. aureus with an efﬁcientmeans of l-lactate catabolism
in the presence of aerobic/anaerobic respiration.
The ability of S. aureus to resist host NO· is key to its
pathogenesis as demonstrated by the iNOS-dependent attenua-
tion of the Δlqo mutant, particularly in l-lactate-rich cardiac
tissue (Figure 5). How S. aureus continues to catabolize host
tissue in the presence of NO· given the numerous metabolic tar-
gets of this immune radical is still unclear. However, here we
demonstrate that Lqo provides another NO·-resistant pathway
to S. aureus when growing in a peptide/l-lactate-rich environ-
ment. Unlike glucose, individual gluconeogenic substrates do
not allow S. aureus to circumvent the metabolic constraints
imposed by exogenous NO· (Figure 5A). The reasons behind
this phenomenon are unclear, but perhaps the multiple TCA
cycle targets of NO· limit growth on amino acids. However,
combining l-lactate with peptides does restore NO·-resistance to
S. aureus in an Lqo-dependent fashion, though the physiolog-
ical reasons are still unclear (Figure 5A). d-lactate was unable
to support growth under NO·-stress in combination with pep-
tides whereas pyruvate could independently of Lqo (data not
shown). These data are consistent with the requirement for pyru-
vate combined with peptides to allow NO·-resistant growth in
the absence of glucose. It should be noted that the difference
in NO·-resistance between WT and Δlqo in peptide/l-lactate
medium was more robust with a slow releasing NO·-donor such
as DETA/NO. There were reproducible differences between WT
and Δlqo growth in peptide/l-lactate medium under high NO·
levels (∼1mM as in Figure 1), but they manifested as extended
lag phases rather than altered growth rates (data not shown).
This is consistent with the requirement of Lqo for some level
of respiratory activity involving a terminal electron acceptor. At
millimolar NO·-levels, nearly all measurable respiration, both
aerobic and anaerobic, is inhibited. However as NO· dissipates
to sub-millimolar levels (Figure 1B), S. aureus may be able to
respire using molecular oxygen mediated by a NO·-resistant aer-
obic respiratory system. Indeed, Lqo-dependent utilization of
l-lactate/peptides in the presence of NO· was eliminated in the
ΔqoxBACD mutant implying that the cytochrome-aa3 quinol
oxidase is essential for Lqo activity (Figure A6 in Appendix).
While the genes encoding the cytochrome bd quinol oxidase
are induced by NO· (Richardson et al., 2006; Hochgrafe et al.,
2008), this oxidase does not seem to support growth on l-
lactate/peptides during NO·-stress (Figure A6 in Appendix). The
requirement for Lqo during infection of murine cardiac tis-
sue implies that NO·/O2 levels are likely amenable to active
cytochrome-aa3 supporting Lqo-dependent l-lactate utilization.
Alternatively, during infection S. aureus may utilize ﬂavohe-
moglobin (Hmp)-derived nitrate from NO·-detoxiﬁcation as a
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terminal electron acceptor supporting Lqo-mediated l-lactate uti-
lization. More work is required to elucidate the nature of the
relevant S. aureus electron acceptor under NO·-stress during
infection.
The fact that either Lqo or Ldh1/2 can support growth on l-
lactate anaerobically with nitrate represents a signiﬁcant difference
from the exclusive requirement for Lqo during l-lactate/peptide
utilization under NO· stress (Figure 6). For Ldh1/2 to catabo-
lize l-lactate via the reversal of Eq. 1, a respiratory system must
be present to recycle NADH. Since respiration is also required
for Lqo function during NO·-stress, that same respiratory activity
should be able to recycle the NADH produced by Ldh1/2. This is
not the case however, thus NO· must inhibit some other aspect
of oxidative phosphorylation unique to the direct recycling of
NADH. One explanation is that NO· may inhibit the NADH-
dehydrogenase expressed during NO·-exposure (Figure 6). This
would not affect Lqo activity but would limit the utility of Ldh1/2
even in the presence of a usable electron acceptor. Future exper-
imentation will be directed at deﬁning the effects of NO· that
necessitate Lqo activity speciﬁcally for the utilization of l-lactate
during NO·-stress.
While the role of Lqo in NO·-resistant l-lactate/peptide catab-
olism raises important metabolic questions, its disproportionate
contribution to virulence in tissues with excess l-lactate (e.g., car-
diac muscle tissue) has intriguing implications regarding S. aureus
pathogenesis. While muscle tissue can have excessive amounts of
FIGURE 6 | Model of S. aureus lactate metabolism. During respiratory
lactate catabolism (either aerobically or anaerobically on nitrate), S. aureus
can use either Lqo or reversal of the NADH-dependent Ldh1/2 provided
NADH can be recycled. In the absence of an external electron acceptor, S.
aureus is unable to catabolize lactate because Lqo activity requires a
functioning quinol oxidase as does Ldh1/2 for NAD+ regeneration. Initially
during NO· stress, respiration is inhibited and lactate is produced for redox
balance (NAD+ generation). Once respiration resumes due to waning NO·
levels, lactate can be assimilated but only in an Lqo-dependent fashion.
Despite the presence of active quinol oxidases (Qox, Cyd, or Nar)
NADH-dependent Ldh1/2 do not promote lactate assimilation in the
presence of NO·. This would be consistent with NO·-dependent inhibition
of Ndh, limiting NAD+ regeneration even in the presence of active quinol
oxidases, though this remains to be demonstrated.
l-lactate given the oxygen demand associated with muscle activ-
ity, other mammalian tissues relevant to S. aureus biology are also
replete with high levels of l-lactate. For instance, human sweat
can have as high as ∼50mM l-lactate, possibly resulting in a role
for Lqo in skin colonization (Sakharov et al., 2010). Moreover,
nasal secretions have also been shown to contain high concen-
trations of l-lactate making the most common site of S. aureus
colonization (the nasal cavity) a prime environment for Lqo activ-
ity (Stierna et al., 1991;Westrin et al., 1992). Thus, while Lqo may
contribute to S. aureus disease, particularly in various forms of
myocarditis and myositis, this newly characterized enzyme may
also have more overarching roles in promoting S. aureus coloniza-
tion. Thus, the identiﬁcation of Lqo as comprising the elusive S.
aureus iLDH activity will provide signiﬁcant insight into the phys-
iology, pathogenesis, and general biology of this very signiﬁcant
human pathogen.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
Staphylococcus aureus was cultivated in Brain Heart Infusion
medium or in chemically deﬁned medium (PN medium) in
which primary carbon sources could be modiﬁed (Pattee, 1976).
Brieﬂy, PN medium is a phosphate-buffered medium composed
of a primary carbon source (variable depending on experi-
ment), nucleobases (Adenine, 5mg/L; Guanine, 5mg/L; Cyto-
sine, 5mg/L; Uracil, 5mg/L; and Thymine, 20mg/L), free amino
acids (Ala, 60mg/L; Arg, 70mg/L; Asp, 90mg/L; Cystine, 20mg/L;
Glu 100mg/L; Gly, 50mg/L; His, 30mg/L; Iso, 30mg/L; Leu,
90mg/L; Lys, 70mg/L; Met, 10mg/L; Phe, 40mg/L; Pro, 10mg/L;
Ser, 30mg/L; Thr, 30mg/L; Trp, 10mg/L; Tyr, 50mg/L; and Val,
80mg/L), vitamins (thiamine, 1mg/L; niacin, 1.2mg/L; biotin,
5μg/L; and pantothenate, 250μg/L), FeCl3 at 8mg/L, MgSO4 at
2.5mg/L, and trace elements (ZnCl, 70μg/L;MnCl, 63μg/L; Boric
Acid, 6μg/L; CoCl2, 190μg/L; CuCl2, 2μg/L; NiCl2, 13μg/L;
and Na2MoO4, 31μg/L). Aerobic growth was achieved by shak-
ing (250 rmp) in ﬂasks or slanted test tubes where as anaer-
obic cultivation was performed in a Coy anaerobe chamber.
Antibiotic selection in S. aureus (E. coli) was performed using
the following concentrations: ampicillin (100μg/ml), chloram-
phenicol 20μg/ml, kanamycin 50μg/ml (50μg/ml), spectino-
mycin 100μg/ml (500μg/ml), erythromycin 5μg/ml (300μg/ml)
unless otherwise indicated. Growth was monitored as change in
absorbance (660 nm) assessed using a Tecan inﬁnite M200 plate
reader in 200μl cultures within a 96 well plate. To assess the
inability to grow in deﬁned media with l- or d-lactate as a pri-
mary carbon source, residual growth on medium components
was subtracted from growth in media replete with lactate car-
bon sources. Residual growth in media lacking primary carbon
sources halted at OD660 = 0.2–0.3. Mutations were constructed
using a modiﬁed allelic exchange method involving the cloning
of ﬂanking DNA sequence on either side of a selectable marker
in the S. aureus/E. coli shuttle vector, pBT2ts. This construct was
electroporated into S. aureus as previously described and grown
with selection at 30˚C. Cointegration was achieved by growing
cultures overnight with selection at 43˚C followed by plating on
antibiotic containingmedia (Bruckner,1997). Single colonieswere
isolated from 43˚C and grown overnight for three consecutive days
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without antibiotic selection at 30˚C. Finally, cultures were diluted
1:100 and grown to mid-exponential phase at 37˚C at such time
chloramphenicol was added (10μg/ml) to inhibit the growth of
resolved cointegrates. After 30min, cycloserine was administered
(100μg/ml) to selectively kill CmR-cointegrates. After ≥4 h incu-
bation at 37˚C, surviving cells are plated on selective media and
screened for successful allelic replacement.
VIRULENCE ASSESSMENT
Four to 6-week-old female C57BL/6 mice were inoculated i.v. via
tail vein with 5× 106 cfu in 100μl of S. aureus strain Newman
or isogenic mutants. Weight loss was monitored daily for 1week
as a metric for disease progression, mice exhibiting ≥30% weight
loss were sacriﬁced as per IACUC approved protocol. Alterna-
tively,WT mice or isogenic iNOS−/− mice (Jackson Laboratories)
were similarly infected with 1× 107 cfu of WT S. aureus strain
Newman at a 1:1 mixture with isogenic Δlqo and tissue harvested
5 days post-inoculation. Kidneys and hearts were extracted, and
ratios of Δlqo:WT were determined by plating on selective and
non-selective media. Competitive indices (C.I.s) were calculated
as d5 organ burden ratio (Δlqo/WT) divided by inoculation ratio
(Δlqo/WT).
ENZYMATIC DETERMINATION OF METABOLITE LEVELS
Metabolites such as l- and d-lactate, glucose and nitrate were
quantiﬁed as previously described as per manufacturer instruc-
tion (Richardson et al., 2008). Excreted metabolite levels from S.
aureus cultures were determined using supernatants from 1ml of
pelleted, heat-inactivated (70˚C for 5min) cells. Tissue metabo-
lites were extracted from organs (liver, heart, kidneys) harvested
immediately from individual mice (in triplicate) following euth-
anization via cervical dislocation as per approved IACUC pro-
tocols. The organs were quickly homogenized in PBS at 4˚C,
quenched with ice cold methanol (ﬁnal 80% v/v) and frozen at
−80˚C. Subsequently, tissues were thawed and metabolites were
extracted by adding chloroform and water to achieve a ﬁnal
ratio methanol:chloroform:water (4:4:3). The aqueous phase was
removed, lyophilized, and resuspended in 100μl ddH2O for analy-
ses. Lactate and glucose levels were normalized to organ weight
(mg tissue).
FLUORESCENT IMMUNOHISTOCHEMISTRY
Immunohistochemistry on heart tissues was performed as previ-
ously described with minor modiﬁcations (Thurlow et al., 2011).
Heart tissue was collected 5 days post-inoculation and ﬁxed in
10% formalin then parafﬁn embedded and sectioned (10μm) by
the Histopathology Core Facility at UNC. Sections were deparaf-
ﬁnized using a graded series of xylene and ethanol washes followed
by microwaving for 20min in 10mM NaCl buffer (pH 6) for
antigen retrieval. Tissue sectionswere stainedwith primary rabbit-
derived antibodies against iNOS (Abcam, Cambridge, MA, USA)
and secondary donkey anti-rabbit biotin conjugated antibodies
(Jackson ImmuoResearch Laboratories,West Grove, PA,USA) fol-
lowed by the addition of DyLight™594-conjugated streptavidin
(Jackson ImmunoResearch). Images were acquired using a Leica
SP2 confocal microscope (Leica Microsystems, Buffalo Grove, IL,
USA).
MEMBRANE PREPARATIONS AND Lqo/Mqo ENZYMATIC ASSAYS
Overnight S. aureus cultures (Δlqo tomeasureMqo activity,Δmqo
to determine Lqo activity, and ΔmqoΔlqo for background activ-
ity) were diluted 1:100 in 100ml of LB medium (low glucose to
prevent Mqo repression) and shaken at 37˚C until OD660 =∼0.8.
Cells were pelleted, washed in PBS then incubated at 37˚C in
the presence of Lysostaphin (12.5μg/ml), Lysozyme (12.5μg/ml),
DNase (10μg/ml), and RNase (10μg/ml) for 1 h. Debris was pel-
leted and supernatants ultracentrifuged at 100,000 g for 1 h at
4˚C. Membrane fraction pellets were resuspended then sonicated
and protein was quantiﬁed using BCA procedure (Pierce). Reac-
tion mixtures contain 1mg total membrane protein, 40μg nitro
blue tetrazolium (NBT), 5mM KCN, and were initiated by addi-
tion of 20mM substrate (malate/l-lactate) in a ﬁnal volume of
200μl. Reaction progress is monitored by measuring absorbance
at 585 nm every 30 s for 20min using a Tecan inﬁnite M200 plate
reader.
Lqo AND Mqo PURIFICATION AND ANALYSES
C-terminalHis6-tagged versions of Lqo andMqowere constructed
by amplifying alleles from S. aureus strain COL chromoso-
mal DNA using primers Mqo2_His.1A/1B and Mqo1_His.1A/1B,
respectively, and cloning into the NcoI/BamHI sites of pQE-60
(Qiagen). Resulting constructs (pJF132 and pJF133) were trans-
formed into E. coli M15 (pREP4; Qiagen)maintained at 37˚C with
kanamycin (25μg/ml) and ampicillin (200μg/ml). For puriﬁca-
tion, 1 L cultures were seeded with 20mL overnight cultures, and
grown at 25˚C for 4 h with selection and the addition of IPTG
(0.1mM). Subsequently, cells were pelleted, washed in PBS and
lysed via soniﬁcation. Enzymes were puriﬁed using HisPur Cobalt
Puriﬁcation System (Pierce) as per manufacturer instruction. Elu-
tions were dialyzed twice for 2 h at 4˚C followed by an overnight
dialysis at 4˚C against high-salt (300mM NaCl) PBS. Yields were
quantiﬁed using BCA Protein Quantiﬁcation Kits (Pierce).
Enzymatic activity forMqo and Lqowasmonitored by addition
of 100 ng puriﬁed His6-Tagged protein (1μg if using non-speciﬁc
substrate) in a 200μl reaction mixture consisting of 1.4mM
menaquinone, 5μM ﬂavin adenine dinucleotide (FAD), 643μg
phosphatidylethanolamine (PE), 40μg NBT and 20mM substrate
(malate/l-lactate). Prior to addition of enzyme, reaction mix was
sonicated to uniformly disperse menaquinone within the PE vesi-
cles. Reactions were initiated by addition of substrate and followed
via monitoring absorbance at 585 nm using a Tecan inﬁnite M200
plate reader.
RNA EXTRACTION AND QUANTITATIVE REVERSE-TRANSCRIPTASE PCR
Cells were grown in PN chemically deﬁnedmedium supplemented
with either 0.5% glucose, 1.0% l-lactate, or 1.0% tryptone as pri-
mary carbon sources. Once cells reached OD660 = 0.5, 25ml of
culture was added to 25ml of ice cold ethanol:acetone (1:1) and
incubated at−80˚C until further use. Frozen cell suspensions were
thawed at room temperature, pelleted by centrifugation and resus-
pended in 500μl of TE for mechanical disruption using Lysing
Matrix B (MP Biomedicals, Solon, OH, USA) in a standard cell
disruptor. Hundred microliter of lysates was used for RNA isola-
tion using an RNAEasy® Mini Kit (Qiagen, Valencia, CA, USA) as
per manufacturer instructions.
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RNA was spectrophotometrically quantiﬁed and 50 ng of total
RNA was analyzed per reaction using the OneStep™SYBR® RT-
PCR kit (Quantace, Valencia, CA, USA) on an iCycler Real
Time Machine (BioRad). Primers used for analysis are listed in
Table A1 in Appendix and both mqo and lqo transcript levels were
normalized to those of rpoD.
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APPENDIX
Table A1 | Strains used in this work.
COL WT S. aureus W. Shafer
Newman WT S. aureus W. Shafer
AR0169 S. aureus strain COL Δldh1::ErRΔldh2::KmR Richardson et al. (2008)
AR0173 S. aureus strain Newman Δldh1::ErRΔldh2::KmR Richardson et al. (2008)
AR0194 S. aureus strain COL ΔcydAB::KmR This study
AR0309 S. aureus strain Newman Δddh::SpR This study
AR0310 S. aureus strain Newman Δldh1::ErRΔldh2::KmRΔmqo::SpR This study
AR0312 S. aureus strain Newman Δldh1::ErRΔldh2::KmRΔddh::SpR This study
AR0314 S. aureus strain Newman Δmqo::SpR This study
AR0327 S. aureus strain Newman ΔcydAB::KmR This study
AR0369 S. aureus strain COL Δlqo::SpR This study
AR0370 S. aureus strain COL Δldh1::ErRΔldh2::KmRΔlqo::SpR This study
AR0386 S. aureus strain Newman Δlqo::SpR This study
AR0387 S. aureus strain COL Δldh1::ErR Δlqo::SpR This study
AR0388 S. aureus strain COL Δldh2::KmRΔlqo::SpR This study
AR0418 S. aureus strain COL Δddh::SpR This study
AR0419 S. aureus strain COL Δmqo::SpR This study
AR0420 S. aureus strain Newman Δlqo::SpRΔmqo::SpR This study
AR0421 S. aureus strain COL ΔnarGH ::SpR This study
AR0424 S. aureus strain COL Δlqo::SpRΔmqo::SpR This study
AR0425 S. aureus strain COL Δldh1::ErRΔldh2::KmRΔmqo::SpR This study
AR0455 S. aureus strain COL Δldh1::ErRΔldh2::KmRΔddh::SpR This study
AR0495 S. aureus strain Newman ΔnarGH ::SpR This study
AR0630 S. aureus strain COL ΔqoxBACD::SpR This study
FIGUREA1 | Lqo, and to a lesser extent Ldh2, are required for maximal
growth on L-lactate. Representative growth curve ofWT S. aureus strain
COL and isogenic mutants grown in chemically deﬁned medium
supplemented with 1.0% L-lactate as a primary carbon source. Growth as
determined by absorbance at 660 nm was normalized to minimal growth in
the absence of added carbon.
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pBT2ts Temperature sensitive E. coli /S. aureus shuttle vector (Bruckner, 1997)
pBTE 1.2 kb ermB (ErythromycinR) locus cloned into SmaI of pBT2ts
pBTK 1.4 kb aph-A3 (KanamycinR) locus cloned into SmaI of pBT2ts
pBTS 1.3 kb aad9 (SpectinomycinR) locus cloned into SmaI of pBT2ts
pTR086 5′ and 3′ homology regions of cydAB cloned into pBTK to yield ΔcydAB::SpR
pTR108 5′ and 3′ homology regions of mqo cloned into pBTS to yield Δmqo::SpR
pTR120 5′ and 3′ homology regions of ddh cloned into pBTS to yield Δddh::SpR
pDK004 5′ and 3′ homology regions of lqo cloned into pBTS to yield Δlqo::SpR
pNV004 5′ and 3′ homology regions of qoxBACD cloned into pBTS to yield ΔqoxBACD::SpR
pJS006 1.4 kb SpR cassette replacing the 3.5 kb ClaI fragment within the 6.5 kb narGHIJ locus cloned into pBT2ts.
pJF132 C-term His6-tagged Mqo in pQE-60
pJF133 C-term His6-tagged Lqo in pQE-60
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FIGUREA2 | Lqo and Mqo are differentially required for utilization of
various carbon sources.TOP: Neither Mqo nor Lqo are essential for
growth in chemically deﬁned media using glucose (0.5%) as a primary
carbon source. BOTTOM:While Mqo is dispensable for growth on L-lactate
(Figure 2) it is essential for maximal growth in chemically deﬁned media
using amino acids (0.5% Cas Amino Acids) as a primary carbon source.
FIGUREA3 | lqo is highly expressed under a variety of culture
conditions.Total RNA was extracted from S. aureus strain COL grown in
chemically deﬁned medium with either 0.5% Glucose, 1.0% L-lactate, or
1.0% tryptone as primary carbon sources. Quantitative RT-PCR was
performed using primers speciﬁc for lqo and transcript levels were
normalized to rpoD. Data are depicted relative to lqo transcript levels from
cells grown on Glucose.
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FIGUREA4 | Lqo-mediated growth on L-lactate under anaerobiosis
requires an electron acceptor. (A) Representative growth curve ofWT S.
aureus strain Newman and isogenic mutants cultured anaerobically in
chemically deﬁned medium with 1.0% L-lactate as the primary carbon source.
When indicated, nitrate was added (NO−3 at 40mM) as an anaerobic
respiratory electron acceptor. (B) Representative growth curve ofWT
S. aureus strain Newman and isogenic mutants cultured anaerobically in
chemically deﬁned medium with a combination of 1.0% tryptone and
L-lactate as the primary carbon source.When indicated, nitrate was added
(NO−3 at 40mM) as an anaerobic respiratory electron acceptor.
FIGUREA5 | Both Mqo and Lqo are required for full virulence in
S. aureus. Eight female C57BL/6 mice (two independent experiments each
involving four mice per group) were inoculated i.v. with 5×106 cfu of S.
aureus strain Newman or isogenic mutants.Weight loss was documented
and mice losing ≥30% of their body weight at the time of inoculation were
sacriﬁced as per approved IACUC protocols.
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FIGUREA6 | Cytochrome-aa3 (QoxBACD) is required for Lqo activity
during NO·-stress. Representative growth curve onWT S. aureus strain
COL and isogenic mutants grown in chemically deﬁned medium using a
combination of 0.1% L-lactate/1.0% tryptone as primary carbon sources in
the presence of low level NO· (administered as 10mM DETA/NO when
cultures reach A660 =0.15).
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